-
Appeals Court Affirms Truck Driver’s Workers’ Compensation for Mesothelioma
Malignant mesothelioma claimed North Carolina truck driver Tommy Lineberger’s life in 2018, and his widow has been fighting for compensation since shortly after his death. Though the North Carolina court that administers workers’ compensation benefits found her claim eligible for compensation from his former employers, both companies appealed, arguing that her claim exceeded the governing…
-
California’s Fire Clean-up Rules Driven by Concerns Over Mesothelioma and Other Illnesses
Mesothelioma and other asbestos-related diseases are generally caused by occupational exposure. But wildfires and other disasters can also release the carcinogenic fibers into the air, and this is having an impact on the wildfire debris cleanup in Los Angeles. Owners and operators of facilities damaged in the fires are being reminded of the regulations imposed…
-
Mesothelioma Concerns Drive FDA Talc Evaluation Proposal
Over the last several years, tens of thousands of people diagnosed with mesothelioma and other cancers linked to asbestos have blamed contaminated talc in consumer products for their illnesses. While pharmaceutical and food companies have denied that talc in their products is dangerous, rising concerns have led a panel of scientific experts to raise the…
-
Shipyard Worker’s Mesothelioma Lawsuit Cites 30 Years of Asbestos Exposure Copy
Robert Stephen Sentilles is pursuing justice against multiple companies that he blames for his malignant mesothelioma. In his lawsuit, which points primarily to his former employer, Avondale Shipyards, he cites numerous products made with the toxic material that he worked with over the years.
-
Medical Journal Rejects J&J Pressure to Retract Mesothelioma Article
Over the last several years, consumer giant Johnson & Johnson has been fending off legal claims filed by mesothelioma and ovarian cancer victims who blame talc in their popular baby powder product for their illnesses. The company’s efforts have included litigation, a controversial bankruptcy maneuver, and arguing against the veracity of scientific inquiries and reports.…
-
Mesothelioma Lawsuit Cites Asbestos in IBM Selectric Typewriters
A 74-year-old Ohio woman diagnosed with malignant mesothelioma has traced her history of exposure to asbestos to her decades of working with typewriters and other equipment manufactured and sold by International Business Machines (IBM). She recently filed suit against the company in New York’s Supreme Court of Westchester County.
-
Massachusetts Jury Awards $8 Million to J&J Mesothelioma Victim
A Boston jury has ordered Johnson & Johnson to pay $8 million to an 84-year-old woman who was diagnosed with pleural mesothelioma after a lifetime of using the company’s baby powder product on herself and her seven children. The jury agreed that the talcum powder used by the company was contaminated with asbestos, that the company…
-
Louisiana Court Rules on Mesothelioma Insurance Coverage Case
When a mesothelioma victim or their family pursues legal justice or compensation for their illness, the insurance companies that provided liability coverage for the asbestos companies or other defendants are often included in the claim. In a recent Louisiana appellate decision involving a man who died from the asbestos-related disease, the Louisiana Court of Appeal,…
-
Mesothelioma Advocates Fear EPA Asbestos Policy Reversal Puts Lives at Risk
Mesothelioma advocates are expressing alarm after the Environmental Protection Agency filed a motion to delay a planned ban on the use of chrysotile asbestos and reconsider the rule that put it in place. The ban was adopted last year under the Biden administration. If the filing submitted by the Trump administration is approved, the reconsideration…
-
FDA Grants New Mesothelioma Treatment Orphan Drug Designation
The United States Food and Drug Administration has granted orphan drug designation to a new pleural mesothelioma treatment called MVdeltaC. Orphan drug designation is a special category of approval for treatments targeting rare diseases. It both speeds up the development process and offers financial incentives to encourage researchers to continue their work on therapies that…
-
Canadian Veterans Review Board Awards Compensation to Veteran with Cancer
Veterans who served in the U. S. military suffered significant asbestos exposure between the 1930s and 1980s, and as a result, they represent a disproportionate ratio of the mesothelioma diagnoses in this country. But mesothelioma is not the only cancer caused by asbestos exposure, and American veterans aren’t the only ones who were exposed. In…
-
Study Reveals Asbestos-Related Mesothelioma Has Unique Gene Expression Pattern
A recent study has delivered significant results about the role that asbestos plays in the development of pleural mesothelioma. Researchers have found that patients who’ve been exposed to the toxic mineral have distinct gene expression profiles. Discovering that it’s the asbestos itself that alters gene activity may pave the way for the development of novel…
-
Mesothelioma Victims Face Justice Delays Over Montana Talc Mine’s Bankruptcy Proceedings
Hundreds of people diagnosed with mesothelioma and other deadly asbestos-related diseases have found themselves caught in a legal battle that has delayed their pursuit of justice and compensation for years. The issue revolves around Barretts Minerals Inc. and its attempt to use bankruptcy protection to protect its parent company from personal injury and wrongful death…
-
Asbestos in Philadelphia Schools Raises Concerns About Mesothelioma
Years after a Philadelphia teacher was diagnosed with mesothelioma and another is battling cancer, the Philadelphia Board of Education is negotiating with the U.S. Department of Justice over asbestos management. Though this issue is taking place in Philadelphia, it highlights the risk affecting thousands of students, teachers, and staff across the country’s aging buildings.
-
Italian Researchers Identify Promising Therapeutic Target in Mesothelioma Patients
Pleural mesothelioma is both one of the most aggressive forms of cancer and also largely non-responsive to treatment. To identify therapeutic targets, researchers from the IRCCS Humanitas Research Hospital in Milan, Italy, recently investigated a protein called glycoprotein non-metastatic melanoma protein B (GPNMB), which is secreted by tumor-associated macrophages. Their research confirmed that the protein’s…
-
Louisiana Mesothelioma Victim Sues Asbestos-Contaminated Shipyard
Daniel Cantrelle, Sr., filed a damages lawsuit in Louisiana state court after being diagnosed with mesothelioma in June of 2024. He named several companies as defendants, including Avondale Shipyards, where he worked from 1960 to 1979. The company removed the lawsuit to federal court, arguing that it was entitled to government contractor immunity because it…
-
Bispecific Antibody Plus Chemotherapy Delivers Positive Results in Mesothelioma Patients
Mesothelioma researchers from China have reported promising results following a Phase 2 trial that combined a bispecific antibody form of immunotherapy with platinum chemotherapy. The scientists presented their findings at the 2025 ASCO Annual Meeting.
-
World Trade Center Worker and Wife Awarded $117 Million After Mesothelioma Diagnosis
For the three years since a former World Trade Center worker was diagnosed with malignant mesothelioma, he and his wife have been seeking justice for the harm they’ve both suffered. Last month, a New York jury awarded the man $78 million for his past and future pain and suffering, and an additional $39 million to…
-
Washington Supreme Court Allows Mesothelioma Victim to Sue Former Employer
Ever since Jeffrey Cockrum was diagnosed with malignant mesothelioma in 2022, he has been trying to hold his former employer, Howmet Aerospace, accountable. After his personal injury lawsuit was dismissed by both a trial court and the appellate court based on workers’ compensation rules, he appealed the case to the state’s Supreme Court, which decided…
-
Study Examines Gut Microbiota’s Role in Mesothelioma Drug Response
Mesothelioma researchers from the United Kingdom have made a promising discovery that may help revolutionize treatment for the rare, asbestos-related disease. As part of the ongoing IST4 multi-center phase II clinical trial, they’ve found that bacteria living in the gut – collectively known as the gut microbiota – may play a crucial role in determining…
